Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects
Clinical trial NCT02758171 · COMPLETED
Trial details
- NCT number
- NCT02758171
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-17
- Primary completion
- 2016-07-29
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.